Uncovering potential new biomarkers and immune infiltration characteristics in primary Sjögren's syndrome by integrated bioinformatics analysis

被引:2
作者
Zhang, Naidan [1 ]
Ji, Chaixia [1 ]
Bao, Xiao [2 ]
Peng, Xinyin [3 ]
Tang, Maoju [4 ]
Yuan, Chengliang [1 ]
机构
[1] Peoples Hosp Deyang City, Dept Clin Lab, North Taishan Rd 173, Deyang 618000, Sichuan, Peoples R China
[2] Peoples Hosp Deyang City, Dept Rheumatol, Deyang, Peoples R China
[3] Chengdu Univ Chinese Med, Chengdu, Peoples R China
[4] North Sichuan Med Coll, Nanchong, Peoples R China
关键词
differentially expressed genes; disease ontology annotation; immune infiltration; primary Sjogren's syndrome; receiver operating characteristic curve; SJOGRENS-SYNDROME; SALIVARY-GLAND; EXPRESSION; LYMPHOMA; CELLS; IDENTIFICATION; METHYLATION; LESIONS; GENES; SELL;
D O I
10.1097/MD.0000000000035534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary Sjogren's syndrome (pSS) is known as autoimmune disease characterized by damage to endocrine glands, such as the salivary and lacrimal glands. This study aimed to identify potential biomarkers for pSS using integrated bioinformatics analysis and explore the relationship between differentially expressed genes (DEGs) and immune infiltration. Three pSS datasets (GSE7451, GSE23117, and GSE40611) from the gene expression omnibus database were integrated. All the datasets were processed in R (version 4.0.3). A total of 16 immune cells and 13 immune functions were obtained. The top immune cell and immune function were "activated" dendritic cells and major histocompatibility complex class I. Correlation analysis showed the top correlation among 16 immune cells were B cells and tumor infiltrating lymphocytes, check-point and T cell co-stimulation, respectively. In comparisons of immune score, "activated" dendritic cells (.657 vs 594, P < .001), B cells (.492 vs 434, P = .004), macrophages (.631 vs 601, P = .010), inflammation-promoting (.545 vs 478, P < .001), Type I interferon Reponse (.728 vs 625, P < .001) and so on were higher in pSS than control group. In correlation analysis, the up-regulation of interferon induced protein with tetratricopeptide repeats 1 gene was strongly correlated with Type I interferon response with a correlation coefficient of .87. The receiver operating characteristic curve of 5 genes showed that the area under curve was.891. In the verification model, the area under curve was.881. In addition, disease ontology analysis supported the association between DEGs and pSS. In summary, pSS has a variety of DEGs in immune infiltration, which is worthy of the attention from clinicians.
引用
收藏
页数:9
相关论文
共 56 条
  • [1] Genome-Wide DNA Methylation Patterns in Naive CD4+T Cells From Patients With Primary Sjogren's Syndrome
    Altorok, Nezam
    Coit, Patrick
    Hughes, Travis
    Koelsch, Kristi A.
    Stone, Donald U.
    Rasmussen, Astrid
    Radfar, Lida
    Scofield, R. Hal
    Sivils, Kathy L.
    Farris, A. Darise
    Sawalha, Amr H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 731 - 739
  • [2] Memory and naive gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapy
    Anvari, Sara
    Watkin, Levi
    Rajapakshe, Kimal
    Hassan, Oluwatomi
    Schuster, Kimberly
    Coarfa, Cristian
    Davis, Carla M.
    [J]. CLINICAL IMMUNOLOGY, 2021, 230
  • [3] Widespread parainflammation in human cancer
    Aran, Dvir
    Lasry, Audrey
    Zinger, Adar
    Biton, Moshe
    Pikarsky, Eli
    Hellman, Asaf
    Butte, Atul J.
    Ben-Neriah, Yinon
    [J]. GENOME BIOLOGY, 2016, 17
  • [4] Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjogren's syndrome
    Bjork, Albin
    Andersson, Elina Richardsdotter
    Imgenberg-Kreuz, Juliana
    Thorlacius, Gudny Ella
    Mofors, Johannes
    Syvanen, Ann-Christine
    Kvarnstrom, Marika
    Nordmark, Gunnel
    Wahren-Herlenius, Marie
    [J]. RMD OPEN, 2020, 6 (01):
  • [5] Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects
    Brito-Zerón P.
    Retamozo S.
    Gheitasi H.
    Ramos-Casals M.
    [J]. Drugs, 2016, 76 (17) : 1601 - 1623
  • [6] The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjogren's Syndrome
    Brown, Sarah
    Coy, Nuria Navarro
    Pitzalis, Costantino
    Emery, Paul
    Pavitt, Sue
    Gray, Janine
    Hulme, Claire
    Hall, Frances
    Busch, Robert
    Smith, Pete
    Dawson, Luke
    Bombardieri, Michele
    Wan-fai, Ng
    Pease, Colin
    Price, Elizabeth
    Sutcliffe, Nurhan
    Woods, Clodagh
    Ruddock, Sharon
    Everett, Colin
    Reynolds, Catherine
    Skinner, Emma
    Poveda-Gallego, Ana
    Rout, John
    Macleod, Iain
    Rauz, Saaeha
    Bowman, Simon
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [7] Bioinformatics Analysis for Identification of Key Genes in Salivary Gland and the Potential of a Combination of Biomarkers for the Diagnosis of SS
    Chen, Liying
    Lu, Dingqi
    Yu, Kai
    He, Shiya
    Liu, Liu
    Zhang, Xvfeng
    Feng, Bo
    Wang, Xinchang
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 4143 - 4153
  • [8] Lymphoma and Sjogren Syndrome: A Common Overlapping Syndrome?
    Chen, Yu-Wen
    Tsai, Po-Yu
    Wei, James Cheng-Chung
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (08)
  • [9] Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis
    Dashti, Navid
    Mahmoudi, Mahdi
    Gharibdoost, Farhad
    Kavosi, Hoda
    Rezaei, Ramazan
    Imeni, Vahideh
    Jamshidi, Ahmadreza
    Aslani, Saeed
    Mostafaei, Shayan
    Vodjgani, Mohammad
    [J]. RHEUMATOLOGY INTERNATIONAL, 2018, 38 (03) : 489 - 498
  • [10] Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases
    Di Benedetto, Paola
    Ruscitti, Piero
    Vadasz, Zahava
    Toubi, Elias
    Giacomelli, Roberto
    [J]. AUTOIMMUNITY REVIEWS, 2019, 18 (10)